Literature DB >> 11791758

Effects of red cell storage and lysis on in vitro cytokine release.

T Mynster1.   

Abstract

Cytokine release in whole blood assays is inhibited by addition of supernatants from stored blood components in a storage time dependent manner. This is also observed after prestorage leucofiltration of the blood. The role of erythrocyte changes during storage is unknown. In this study, we have therefore used prestorage leucofiltered buffy coat-depleted red blood cells stored for 35 days. Assays of whole blood with addition of either complete suspension or only supernatant from the stored blood units were stimulated with lipopolysaccharide (LPS) and incubated. Additionally, samples from the stored blood units were partly haemolysed and added to similar whole blood assays. After incubation, tumour necrosis factor-alpha (TNF-alpha) and interleukin-10 (IL-10) concentrations were determined. Results showed that the TNF-alpha release was not changed by addition of supernatants from prestorage leucofiltered blood, but significantly decreased with addition of red cell suspension in a storage time dependent manner. The IL-10 release increased with storage time with addition of both red cell suspension and supernatant. The TNF-alpha/IL-10 ratio decreased with storage time, but significantly more, 25% vs. 10%, during the 35 days, with addition of suspension compared with addition of supernatant. TNF-alpha and IL-10 release was not changed by addition of supernatant from lysed erythrocytes of various storage times. Therefore, storage time dependent inhibition of immune response by red cell suspension may in part be dependent on red cell presentation, and may cause some of the side effects by transfusion of red cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11791758     DOI: 10.1016/s1473-0502(01)00081-7

Source DB:  PubMed          Journal:  Transfus Apher Sci        ISSN: 1473-0502            Impact factor:   1.764


  6 in total

1.  An explanation for the worsened prognosis in some cancer patients of perioperative transfusion: the time-dependent release of biologically active growth factors from stored blood products.

Authors:  Tahwinder Upile; Waseem Jerjes; Jaspal Mahil; Navdeep Upile; Holger Sudhoff; Anthony Wright; Colin Hopper
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-02-24       Impact factor: 2.503

2.  Blood manufacturing methods affect red blood cell product characteristics and immunomodulatory activity.

Authors:  Ruqayyah J Almizraq; Philip J Norris; Heather Inglis; Somaang Menocha; Mathijs R Wirtz; Nicole Juffermans; Suchitra Pandey; Philip C Spinella; Jason P Acker; Jennifer A Muszynski
Journal:  Blood Adv       Date:  2018-09-25

3.  Immunosuppressive effects of red blood cells on monocytes are related to both storage time and storage solution.

Authors:  Jennifer Muszynski; Jyotsna Nateri; Kathleen Nicol; Kristin Greathouse; Lisa Hanson; Mark Hall
Journal:  Transfusion       Date:  2011-10-07       Impact factor: 3.157

4.  The use of specific anti-growth factor antibodies to abrogate the oncological consequences of transfusion in head & neck squamous cell carcinoma: an in vitro study.

Authors:  Tahwinder Upile; Waseem Jerjes; Sandeep Singh; Mohammed Al-Khawalde; Zaid Hamdoon; Hani Radhi; Colin Hopper
Journal:  Head Neck Oncol       Date:  2012-05-16

5.  The impact of two different transfusion strategies on patient immune response during major abdominal surgery: a preliminary report.

Authors:  Kassiani Theodoraki; Maria Markatou; Demetrios Rizos; Argyro Fassoulaki
Journal:  J Immunol Res       Date:  2014-04-03       Impact factor: 4.818

6.  Storage duration of red blood cell transfusion and Clostridium difficile infection: a within person comparison.

Authors:  Mary A M Rogers; Dejan Micic; Neil Blumberg; Vincent B Young; David M Aronoff
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.